Stay updated on Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added; Revision: v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:34:29.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a disease tag and a new Genetic and Rare Diseases Information Center resource link. Updated page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T18:18:01.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.2 to v3.4.3; no visible changes to the Study Details page.
    Difference
    0.1%
    Check dated 2026-03-11T16:49:06.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision note v3.4.2 was added and older maintenance notes (v3.4.1) were removed, along with a government-funding status notice. This update affects only site metadata and does not alter study details or results.
    Difference
    0.4%
    Check dated 2026-02-11T05:19:28.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapses was added, and a new publication entry (Chan SL et al., Ann Hepatology, 2025) was added to the Publications section. An existing publication entry was revised to reflect the latest version.
    Difference
    0.5%
    Check dated 2026-02-04T04:50:44.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    UI/text updates include a glossary toggle and new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision: v3.4.0; no changes to core study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:15:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Hepatocellular Carcinoma Clinical Trial page.